Flexible solutions to accelerate your oncology breakthrough

Every year, cancer takes the lives of millions. While the world waits for potential cures and access to treatment, biotech companies are in a race to get new therapeutics to market quickly.

However, with complex oncology trials and the many unknowns that come with next generation therapies, there are endless hurdles. Your scientific discoveries deserve an innovative approach to clinical development.

As a full-service oncology CRO, we are dedicated to supporting biotech and emerging biopharma companies through every phase of development. Our extensive oncology expertise coupled with an end-to-end approach helps accelerate your clinical programs, giving you confidence to bring breakthrough treatments to patients, faster.

Having a streamlined clinical development process can mean the difference between success and failure for emerging biotechs. We’re dedicated to providing end-to-end, consultative solutions and services -- from lab development to clinical delivery.
 
Erin Finot , Vice President, Immuno-Oncology & CAGT

Leading oncology expertise

Oncology is IQVIA Biotech’s largest area of focus.

Our strong foundation of therapeutic, scientific, and operational expertise enables us to bring unparalleled innovation to oncology clinical development, making your trial more precise, predictable and efficient.

  • 500+ studies/70,000 patients in the past 5 years 
  • Experience working in 66 countries 
  • 16 FDA approved oncology therapies
  • Board-certified oncologists and hematologists on staff
  • Global oncology key opinion leaders and site networks
  • Global oncology regulatory expertise 
Contact Us
EARLY PHASE ONCOLOGY

Our extensive early phase oncology experience enables us to guide your program through the intricacies inherent in dose-finding and dose-optimization, safety and proof-of-concept studies in a sick patient population. We look beyond first-in-human, and are active in a range of adaptive, basket and umbrella designs, as well as complex multi-arm platform design trials.

  • Global network of specialist Phase I oncology sites
  • Technology solutions for enhanced cohort planning and management
  • Modeling and simulation of multiple datasets to identify optimal dose of novel targeted and immune therapies
  • Laboratory services from Q2 Solutions for biomarker services, assay validation and development of companion diagnostics
LATE PHASE ONCOLOGY

We offer modern solutions for patient-focused trials that accelerate enrollment, reduce site burden, and deliver trials on time and budget.

  • Proven decentralized trial solutions
  • Global network of trial sites to optimize patient recruitment
  • Precision site selection, centralized monitoring, and automated safety case processing
  • Global regulatory expertise
Experience by phase

Early and late phase expertise

IQVIA Biotech has staff with specific early phase and late phase experience to address the nuances of different phases of development and can grow with you as your pipeline matures.

Trending Topics in Oncology

I am delighted to work alongside biotech sponsors in the exciting world of oncology drug development. We experience the highs and lows with our customers, and nothing is more rewarding than helping a customer successfully bring a new treatment to patients.
 
Gerhard du Toit , GLOBAL HEAD, ONCOLOGY

Cancer affects us all in one way or another. We're committed to help innovative biotechs leverage advanced data and build patient centered trial strategies to bring novel treatments to the patients who need them.


Matt Simmons, Senior Director, Oncology Strategy

Connected Intelligence for oncology clinical development

By making intelligent connections across an expansive portfolio of capabilities, unparalleled data and therapeutic expertise, we bring innovation to the needs of today’s oncology development to help you focus on the patient, manage trial complexity, and increase predictability and speed. 

Learn More
Related Solutions
Real World Solutions

Generate and disseminate the right real world evidence (RWE) to meet stakeholder needs with confidence.

Decentralized Trials

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are.

Cell & Gene Therapy COE

Access new resources for advanced therapy development, from candidate identification through market authorization.

IQVIA Biotech's oncology resource center